CoviTact
Start date:14/12/2020 Main trial site:
Royal Infirmary of Edinburgh
The CoviTact trial aims to collect saliva samples from COVID positive and negative patients in order to evaluate a new assay developed to detect the presence of SARS-COVID 2.
Samples are collected as part of ongoing studies and will be tested using the novel assay and via PCR.
Research Team
Julia Grahamslaw
Lead Research Nurse
More EMERGE Trials
Assisting in identifying patients with Humeral shaft fractures in the ED by screening.
Giving patient information sheets to introduce the study, so patient has had adequate time to read and make decision about going into the trial before going to the fracture clinic.
HU-FIX Trial
Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS) by laboratory analysis of biological samples from recreational drug users.
IONA Study
Identification of Novel Psychoactive Substances (IONA)